The global Cytomegalovirus (CMV) treatment market is projected to grow from USD 627.36 million in 2024 to USD 1,035.16 million by 2032, expanding at a CAGR of 6.5% during the forecast period. CMV, a member of the herpesvirus family, affects people of all ages and is especially dangerous in immunocompromised individuals such as transplant recipients, HIV...
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek